| |
|
|
|
AzurRx BioPharma Inc.  
|
|
0.87 -0.02 (-0.02%) |
01-15 16:00 |
|
Open: |
0.8555 |
Pre close: |
0.89 |
Target:
|
1.22
|
|
High: |
0.8755 |
Low: |
0.8445 |
Resistance:
|
1.05
1.24
|
|
Volume: |
2,036,337 |
Market Cap: |
30M |
Support:
|
0.73
0.61
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.90
 |
MACD |
MACD(12,26):
|
0.03  |
|
MA(20): |
0.85 |
Signal(12,26,9): |
0.03 |
|
MA(100): |
0.78 |
Stochastic Oscillator |
%K(14,3):
|
26.99 |
|
MA(250): |
0.81 |
%D(3): |
31.68 |
|
Average Volume(K) |
3-Month: |
127646
|
52-Week |
High:
|
1.30 |
|
10-Days: |
628928 |
Low: |
0.37 |
|
RSI |
RSI(14):
|
53.12 |
Change(%): |
-20.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.899 |
Return on Equity (ttm) |
-191.7 |
Shares Out. (M) |
30.95 |
|
EPS Est. Current Year |
-0.850 |
Return on Assets (ttm) |
-48.5 |
Shares Float (M) |
28.30 |
|
EPS Est. Next Year |
-0.670 |
PEG Ratio |
0.00 |
% Held by Insiders |
11.09 |
|
EPS Est. Next Quarter |
-0.160 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
5.14 |
|
Forward EPS |
22425564.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
111 |
|
Book Value (p.s.) |
0.490 |
EBITDA (p.s.) |
-0.322 |
P/E |
-0.97 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.78 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-8.56 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.29 |
P/CF |
-3.15 |
|
|
|
|
|
|
